Dr. Paul Smith, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,845 | 130 | 82.7% |
| Travel and Lodging | $583.89 | 3 | 17.0% |
| Education | $13.01 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $958.47 | 21 | $0 (2023) |
| Astellas Pharma US Inc | $455.75 | 28 | $0 (2024) |
| ABBVIE INC. | $313.21 | 13 | $0 (2022) |
| NeoTract Inc. | $249.99 | 2 | $0 (2018) |
| Endo Pharmaceuticals Inc. | $247.03 | 15 | $0 (2024) |
| NxThera, Inc. | $205.97 | 11 | $0 (2018) |
| C. R. BARD, INC. & SUBSIDIARIES | $131.22 | 3 | $0 (2019) |
| Sumitomo Pharma America, Inc. | $114.46 | 6 | $0 (2024) |
| Allergan, Inc. | $111.10 | 7 | $0 (2021) |
| Coloplast Corp | $97.63 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $205.42 | 10 | Sumitomo Pharma America, Inc. ($57.05) |
| 2023 | $849.02 | 16 | Boston Scientific Corporation ($642.32) |
| 2022 | $205.84 | 7 | Coloplast Corp ($97.63) |
| 2021 | $267.42 | 17 | Astellas Pharma US Inc ($181.49) |
| 2020 | $68.98 | 4 | Boston Scientific Corporation ($19.06) |
| 2019 | $712.42 | 29 | Boston Scientific Corporation ($168.75) |
| 2018 | $740.12 | 29 | NeoTract Inc. ($249.99) |
| 2017 | $393.09 | 22 | NxThera, Inc. ($169.13) |
All Payment Transactions
134 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: UROLOGY | ||||||
| 10/29/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: UROLOGY | ||||||
| 10/21/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Oncology | ||||||
| 10/15/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $28.21 | General |
| Category: ONCOLOGY | ||||||
| 08/13/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $25.12 | General |
| 07/31/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: UROLOGY | ||||||
| 07/25/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 07/15/2024 | Endo USA, Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: UROLOGY | ||||||
| 04/01/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: UROLOGY | ||||||
| 02/06/2024 | Endo Pharmaceuticals Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: UROLOGY | ||||||
| 12/11/2023 | Endo Pharmaceuticals Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: UROLOGY | ||||||
| 11/03/2023 | Boston Scientific Corporation | — | Travel and Lodging | Cash or cash equivalent | $288.61 | General |
| Category: General - BPH_URO | ||||||
| 11/03/2023 | Boston Scientific Corporation | — | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: General - BPH_URO | ||||||
| 11/03/2023 | Boston Scientific Corporation | — | Travel and Lodging | Cash or cash equivalent | $17.32 | General |
| Category: General - BPH_URO | ||||||
| 11/02/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Urology | ||||||
| 10/24/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Urology | ||||||
| 09/22/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Urology | ||||||
| 09/22/2023 | Boston Scientific Corporation | Moses 550 D\F\L (Device) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Moses 550 D F L_URO | ||||||
| 09/20/2023 | Boston Scientific Corporation | — | Travel and Lodging | In-kind items and services | $277.96 | General |
| Category: General - Therapies_URO | ||||||
| 09/13/2023 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: Urology | ||||||
| 07/26/2023 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: ONCOLOGY | ||||||
| 05/23/2023 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: rezum_URO | ||||||
| 05/15/2023 | Medtronic, Inc. | POLYSORB (Device) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Wound Closure | ||||||
| 04/24/2023 | Olympus America Inc. | Soltive (Device) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: Urology Gynecology | ||||||
| 03/31/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 2,046 | 2,654 | $403,728 | $141,351 |
| 2022 | 18 | 1,874 | 2,481 | $351,758 | $124,750 |
| 2021 | 17 | 1,707 | 2,399 | $329,268 | $127,540 |
| 2020 | 19 | 1,650 | 2,316 | $323,527 | $112,696 |
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 497 | 655 | $119,330 | $40,340 | 33.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 83 | 96 | $46,836 | $17,850 | 38.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 131 | 168 | $43,030 | $16,094 | 37.4% |
| 55875 | Insertion of needle or tube into prostate for radiation therapy | Facility | 2023 | 12 | 21 | $32,880 | $13,445 | 40.9% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 12 | 93 | $40,920 | $12,492 | 30.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 69 | 69 | $23,198 | $8,102 | 34.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 101 | 101 | $22,826 | $7,506 | 32.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 450 | 578 | $13,872 | $4,455 | 32.1% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 12 | 12 | $8,882 | $3,441 | 38.7% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 12 | 12 | $7,768 | $3,171 | 40.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 28 | 29 | $7,628 | $2,999 | 39.3% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 17 | 17 | $6,648 | $2,708 | 40.7% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 20 | 20 | $9,780 | $1,968 | 20.1% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 14 | 14 | $3,960 | $1,468 | 37.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 495 | 656 | $2,624 | $1,441 | 54.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 22 | $3,484 | $1,293 | 37.1% |
| 76965 | Ultrasonic guidance for administration of radiation therapy | Facility | 2023 | 12 | 21 | $2,814 | $1,151 | 40.9% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 17 | 17 | $4,046 | $449.82 | 11.1% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 14 | 18 | $1,224 | $445.76 | 36.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 16 | 16 | $1,028 | $420.96 | 40.9% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 17 | 19 | $950.00 | $110.96 | 11.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 512 | 694 | $123,300 | $43,713 | 35.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 77 | 88 | $43,264 | $16,761 | 38.7% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 13 | 114 | $50,880 | $16,358 | 32.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 143 | 143 | $32,158 | $10,710 | 33.3% |
About Dr. Paul Smith, MD
Dr. Paul Smith, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2008. The National Provider Identifier (NPI) number assigned to this provider is 1659530434.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Smith, MD has received a total of $3,442 in payments from pharmaceutical and medical device companies, with $205.42 received in 2024. These payments were reported across 134 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($2,845).
As a Medicare-enrolled provider, Smith has provided services to 7,277 Medicare beneficiaries, totaling 9,850 services with total Medicare billing of $506,336. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Urology
- Location Houston, TX
- Active Since 06/05/2008
- Last Updated 03/30/2021
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1659530434
Products in Payments
- UroLift (Device) $249.99
- MYRBETRIQ (Drug) $247.81
- XIAFLEX (Biological) $227.03
- Rezum (Device) $205.97
- BOTOX (Biological) $152.40
- XTANDI (Drug) $131.24
- GEMTESA (Drug) $127.64
- Androgel (Drug) $124.52
- Skyrizi (Biological) $113.37
- Altis (Device) $97.63
- GENERAL BPH (Device) $93.93
- LITHOVUE (Device) $92.81
- Myrbetriq (Drug) $92.03
- AVEED (Biological) $69.39
- Da Vinci Surgical System (Device) $62.38
- PROLARIS (Device) $53.06
- GENTLECATH (Device) $50.82
- GENERAL BPH (Device) $44.61
- REZUM (Device) $33.94
- GENERAL - BPH (Device) $33.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Houston
Sandeep Sahay, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $366,850
Diego Marines Copado, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $287,975
Dr. Eddie Patton, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $235,342
Naveen Pemmaraju, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $198,556
Laila Tabatabai, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $194,524
Syed Naqvi, M.d./M.b.a, M.D./M.B.A
Student in an Organized Health Care Education/Training Program — Payments: $144,401